NASDAQ:BLGO BioLargo (BLGO) Stock Price, News & Analysis $0.21 0.00 (0.00%) As of 02:06 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock About BioLargo Stock (NASDAQ:BLGO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioLargo alerts:Sign Up Key Stats Today's Range$0.20▼$0.2150-Day Range$0.20▼$0.2852-Week Range$0.16▼$0.32Volume246,334 shsAverage Volume272,364 shsMarket Capitalization$63.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.Read More… Receive BLGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLargo and its competitors with MarketBeat's FREE daily newsletter. Email Address BLGO Stock News HeadlinesEarnings call transcript: BioLargo Q1 2025 revenue misses forecast, stock dipsMay 17, 2025 | investing.comBioLargo Inc (BLGO) Q1 2025 Earnings Call Highlights: Strategic Innovations Amid Financial ...May 16, 2025 | finance.yahoo.comAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. June 4, 2025 | Timothy Sykes (Ad)BioLargo, Inc: BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent TechnologiesMay 6, 2025 | finanznachrichten.deEarnings call transcript: BioLargo Q1 2025 reveals strong revenue growthApril 2, 2025 | investing.comBioLargo, Inc. (PNK:BLGO) Q4 2024 Earnings Call TranscriptApril 2, 2025 | insidermonkey.comBioLargo Reports Record Revenue Growth in 2024April 2, 2025 | tipranks.comBioLargo to Present at the AI & Technology Virtual Investor Conference April 3, 2025April 1, 2025 | financialpost.comSee More Headlines BLGO Stock Analysis - Frequently Asked Questions How have BLGO shares performed this year? BioLargo's stock was trading at $0.19 at the start of the year. Since then, BLGO stock has increased by 7.4% and is now trading at $0.2040. View the best growth stocks for 2025 here. How do I buy shares of BioLargo? Shares of BLGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLargo own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLargo investors own include Hydrofarm Holdings Group (HYFM), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Meta Platforms (META), Micron Technology (MU), Petróleo Brasileiro S.A. - Petrobras (PBR) and Clean Energy Fuels (CLNE). Company Calendar Today6/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConstruction Industry Chemicals & allied products Sub-IndustryChemicals Current SymbolNASDAQ:BLGO CIK880242 Webwww.biolargo.com Phone(888) 400-2863Fax949-625-9819Employees30Year Founded1989Profitability EPS (Most Recent Fiscal Year)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.50 million Net Margins-11.45% Pretax Margin-19.65% Return on Equity-39.90% Return on Assets-22.06% Debt Debt-to-Equity Ratio0.03 Current Ratio2.31 Quick Ratio2.24 Sales & Book Value Annual Sales$12.23 million Price / Sales5.18 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book20.87Miscellaneous Outstanding Shares303,611,000Free Float240,168,000Market Cap$63.36 million OptionableNot Optionable Beta0.19 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:BLGO) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.